Pozen Announces Key Leadership Additions

CHAPEL HILL, N.C.--(BUSINESS WIRE)--POZEN Inc. (“POZEN”) (NASDAQ:POZN), a pharmaceutical company committed to developing medicine that transforms lives, today announced appointments to its Executive Leadership Team led by newly appointed Chief Executive Officer, Adrian Adams.

The new appointments, are as follows:

Mark A. Glickman has been named Chief Commercial Officer of POZEN, a newly created position effective immediately, with the intention of becoming Chief Commercial Officer of Aralez Pharmaceuticals upon the completion of the pending merger between POZEN and Tribute;

Help employers find you! Check out all the jobs and post your resume.

Back to news